Search

everythinglearnresearchcommunity

for

Search:↓

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

TrichoFoam™ is a stable option for personalized hair loss treatment with most ingredients remaining effective for 90-180 days.

Financial support and better counseling are needed to make chemotherapy more affordable and manageable for women in Pakistan.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Photodynamic therapy successfully treated skin cancer in a 53-year-old woman.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Hydroxyl radicals cause hair follicle cell death during chemotherapy by reducing Bcl-2 protein levels.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Resveratrol-loaded carriers may help reduce hair loss from chemotherapy when used with scalp cooling.

Cooling can protect hair follicles from chemotherapy damage by reducing drug uptake.

Eyelash loss can temporarily occur from chemotherapy for retinoblastoma.

Dutasteride may help shrink prostate cancer tumors.

Low-dose methotrexate effectively regrows hair in many alopecia areata patients but can cause some side effects.

New strategies like vitamin A and dextromethorphan can help reduce methotrexate side effects and improve patient adherence.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Some pediatric Ewing's sarcoma patients may experience permanent hair loss after chemotherapy, and treatments might not fully restore hair.

Biological therapy boosts the immune system to effectively fight melanoma.

Nurses are exposed to chemotherapy drugs, risking health issues like hair loss, so protective gear and monitoring are needed.

Certain cancer drugs can cause skin issues like rashes and itching.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Brentuximab vedotin chemotherapy can cause long-term hair loss and emotional distress.

Radiotherapy can cause skin fibrosis, which is often overlooked and needs better treatment and evaluation.

FDG PET/CT scans can change cancer treatment plans for dogs.

Gefitinib can cause rare scarring hair loss.

Patients with skin cancer on the scalp and ear in Mexico have specific features and results from their treatments.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.